CNTB earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -4.40. Updated 2026-07-23.
Connect Biopharma Holdings (CNTB) Research Hub
Connect Biopharma Holdings (CNTB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.04 USD (+1.49%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.40, market cap 0.14B. This hub links to the full technical, earnings and options research available for CNTB.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.04 USD (+1.49%) |
| 52-week range | 1.74 USD – 2.93 USD |
| Trend regime | Range |
| 14-day RSI | 44.9 (Bearish) |
| Trailing P/E | -4.40 |
| Market cap | 0.14B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for CNTB
Covered Call on CNTB: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CNTB: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CNTB: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
CNTB technical analysis: range, last 2.04 USD, RSI 44.9, 52w range 1.74 USD–2.93 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CNTB in?
Connect Biopharma Holdings (CNTB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CNTB in an uptrend or downtrend?
As of 2026-09-11, CNTB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CNTB's trailing P/E ratio?
CNTB's trailing P/E is -4.40, with a market cap of 0.14B. See the earnings research page for full valuation detail.
When does CNTB next report earnings?
CNTB is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.32 USD.